Trademark: 76143646
Status Date
Monday, July 25, 2022
Registration Number
2589726
Registration Date
Tuesday, July 2, 2002
Filing Date
Tuesday, October 10, 2000
Published for Opposition
Tuesday, July 17, 2001
5 Pharmaceutical preparations, namely, pharmaceuticals for the treatment of autoimmune or inflammatory disorders
Jul 25, 2022
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jul 25, 2022
Registered And Renewed (Second Renewal - 10 Yrs)
Jul 25, 2022
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jul 25, 2022
Case Assigned To Post Registration Paralegal
Feb 9, 2022
Teas Section 8 & 9 Received
Jul 2, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 24, 2020
Automatic Update Of Assignment Of Ownership
Jul 5, 2012
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jul 5, 2012
Registered And Renewed (First Renewal - 10 Yrs)
Jul 5, 2012
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jul 5, 2012
Case Assigned To Post Registration Paralegal
Jun 26, 2012
Teas Section 8 & 9 Received
Oct 21, 2008
Notice Of Design Search Code Mailed
Apr 21, 2008
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 8, 2008
Assigned To Paralegal
Mar 28, 2008
Teas Section 8 & 15 Received
Oct 25, 2007
Case File In Ticrs
Jul 2, 2002
Registered-Principal Register
Mar 19, 2002
Allowed Principal Register - Sou Accepted
Mar 19, 2002
Assigned To Examiner
Mar 14, 2002
Statement Of Use Processing Complete
Feb 26, 2002
Use Amendment Filed
Oct 9, 2001
Noa Mailed - Sou Required From Applicant
Jul 17, 2001
Published For Opposition
Jul 4, 2001
Notice Of Publication
Feb 26, 2001
Approved For Pub - Principal Register
Feb 16, 2001
Examiner's Amendment Mailed
Feb 15, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
